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Sarcoidosis is a multisystem granulomatous disease of unknown origin. It typically involves the lungs and mediastinal lymph
nodes in a chronic fashion. However, acute syndrome has been reported possibly in response to systemic release of proinﬂammatory cytokines. Acute pulmonary manifestations, especially acute respiratory failure or acute respiratory distress syndrome, remain extremely uncommon in individuals without a prior diagnosis. We present the case of a 41-year-old African
American female, who presented with ARDS. An extensive workup into the cause of her illness remained negative, and she
subsequently succumbed to her illness. A diagnosis of sarcoidosis was made upon autopsy, after exclusion of other granulomatous
illness. The case highlights the need to consider this uncommon diagnosis in patients with unexplained ARDS to guide therapy.

1. Introduction

2. Case

Sarcoidosis is a multisystem granulomatous disease of unknown etiology. Frequently aﬀecting the mediastinal lymph
nodes and lungs, cutaneous, hepatic, and ocular manifestations are also common. It can also involve the myocardium, central nervous system, spleen, and upper respiratory
tract. Involvement is primarily in the form of nonnecrotizing
granuloma formation, in response to T-cell-mediated
delayed hypersensitivity reaction, recruiting macrophages
and release of inﬂammatory cytokines TNF-a and IL-2.
Pulmonary involvement is usually slow, leading to a
chronic interstitial lung disease with progressive dyspnea,
cough, and fatigue ailing aﬀected individuals. Acute pulmonary presentations are uncommon and typically occur in
advanced sarcoidosis in response to infection, bronchospasm, or injury causing deterioration of the respiratory
status. Even less common is an acute initial presentation
with respiratory failure in a previously undiagnosed patient,
with only a handful of cases reported in the English literature. We describe one such case of a young woman with
acute respiratory distress syndrome and respiratory failure
diagnosed as sarcoidosis posthumously (Figures 1 and 2).

A 41-year-old African American female presented to the
emergency department with a cough, dyspnea, fevers, chills,
night sweats, and fatigue.
She had never experienced pulmonary symptoms two
weeks before presentation when she developed a cough and
fever and was prescribed oral levoﬂoxacin for pneumonia by
her primary care physician. Completing a 7-day course of
antibiotics, with unabating symptoms and worsening
dyspnea, she presented to the emergency department for
further treatment.
The examination was remarkable for tachypnea with a
respiratory rate of 30/min, hypoxemia with an oxygen saturation of 87% in room air, and diﬀuse bilateral crackles,
without jugular venous distension, or lower extremity edema.
Blood test was signiﬁcant for white blood cell count of
30,000/µL, lactic acid of 5 mEq/L, and a normal metabolic panel.
Arterial blood gas revealed a pH of 7.17, PaCO2 of 50 mmHg,
HCO3 of 19 mmol/L, PaO2 of 65.3 mmHg, and SaO2 of 87%.
A CT-PE of the chest showed bilateral extensive multifocal inﬁltrates with signiﬁcant hilar and mediastinal
lymphadenopathy and no evidence of pulmonary embolism.
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Figure 1: Histopathology. (a) Low-power view of lung parenchyma showing multiple giant cell formation and granuloma formation. (b)
Giant cell and granuloma formation in hepatic parenchyma. (c) High-power view of granulomas and giant cells in the lymph node.
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Figure 2: Radiographic appearance at presentation.

She was intubated for respiratory distress and admitted
to the medical intensive care unit, with a tentative diagnosis
of sepsis secondary to pneumonia, and started on broadspectrum antibiotics.
A parasite smear and initial blood cultures were negative.
Bronchoscopy done on the day of admission showed
mild diﬀuse erythema without hemorrhage. Given the patient’s repeated desaturation during the procedure, transbronchial biopsies were not performed and the procedure
terminated early. Lavage was sent for cytology, bacterial,
mycobacterial, and fungal stain, and culture.
An echocardiogram showed a hyperdynamic left ventricle with an estimated ejection fraction of 70% with severe

right ventricular dilatation and hypokinesis. Right ventricular systolic pressure was estimated at 80 mmHg with a
tricuspid annular plane systolic excursion (TAPSE) of 1.3.
She continued to worsen, with worsening hypoxia and
diﬃculty with mechanical ventilation, ultimately requiring
airway pressure release ventilation and inhaled epoprostenol. Bronchoalveolar lavage remained negative, for bacteria,
fungi, or Pneumocystis jirovecii sp.
Workup was expanded to include fungal blood cultures,
histoplasma and coccidioides serology, and viral respiratory
panel. Respiratory syncytial virus, adenovirus, inﬂuenza,
parainﬂuenza, human metapneumovirus, human immunodeﬁciency virus (HIV), Ebstein–Barr virus (EBV), and
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Table 1

Author

Symptoms

Duration
of
symptoms

26,
female

Dyspnea, productive
cough, and chest pain

1 month

Year Patient

Sahn et. al. [11] 1974
Suyama et. al.
[12]

1990

55,
male

Dyspnea and fever

10 days

Sabbagh et al.
[9]

2002

50,
male

Dyspnea and
productive cough

3 weeks

Leiba et al. [13] 2004

41,
female

Dyspnea

1 week

Chirakalwasan
2005
and Dallal [14]
Shibata et al.
2007
[10]

33,
male
66,
male

Acute respiratory
distress syndrome
Leg rash, fever, and
acute respiratory failure

Gupta et al. [7] 2011

40,
male

Dyspnea, cough, fever,
malaise, and weight loss

3 weeks

Gera et al. [6]

2014

30,
male

Dyspnea, cough, and
fever

20 days

Arondi et al.
[5]

2016

20, Dry cough, fatigue, and
female
fever

4 days
n/a

1 week

cytomegalovirus (CMV) were negative. Leptospira and pertussis remained negative. Noninfectious workup along autoimmune lines including antinuclear antibody (ANA), antineutrophilic cytoplasmic antibody (ANCA), rheumatoid
factor (RF), anti-cyclic citrullinated peptide (anti-CCP), and
anti-Smith, anti-SCL70, anti-myeloperoxidase (anti-MPO),
anti-ribonucleoprotein (anti-RNP), and anti-PR3 antibodies
all returned negative, with angiotensin-converting enzyme
(ACE) levels on the high end of normal.
She continued to worsen, requiring hemodynamic
support with norepinephrine, epinephrine, and vasopressin, with worsening hepatic function and oliguric renal
failure.
On the third hospital day, she continued to be febrile.
Morning ABG showed a pH of 6.99, PaCO2 of 47.4 mmHg,
HCO3 of 10 mmol/L, PaO2 of 88.2 mmHg, SO2 of 83.2%, and
lactic acid level of 9 mEq/L; after prompt discussion with the
family, the decision was made to start the patient on continuous renal replacement therapy (CRRT) and consider
extracorporeal membrane oxygenation (ECMO) support.
However, the patient developed pulseless electrical activity (PEA) arrest before CRRT could begin, with the
eventual demise of the patient.
An autopsy revealed noncaseating granulomata in hilar
and mediastinal lymph nodes and pulmonary, splenic, and
hepatic parenchyma. Gram, Ziehl–Neelsen, and special
stains were negative for bacterial, mycobacterial, fungal, or
parasitic organisms.

Radiographic ﬁndings

Biopsy

Treatment and
outcome

Bilateral diﬀuse inﬁltrates
Open lung
Improvement with
without adenopathy
biopsy
prednisone
Diﬀuse small nodular
Transbronchial Improvement with
opacity, with bilateral
lung biopsy
prednisone
lymphadenopathy
Extensive bilateral
Transbronchial Improvement with
interstitial inﬁltrates
lung biopsy
prednisone
Mediastinal
Bilateral reticulonodular
Improvement with
lymph node
opacities
prednisone
biopsy
Bilateral pulmonary
Transbronchial Improvement with
inﬁltrates
lung biopsy methylprednisolone
Bilateral ground glass
Improvement with
Skin biopsy
opacity
steroids
Bilateral patchy ground
glass opacity with
Improvement with
Lung biopsy
interlobular thickening
methylprednisolone
and scattered nodules
Bilateral
lymphadenopathy and
Transbronchial Improvement with
conﬂuent alveolar
biopsy
prednisone
opacities with air
bronchograms
Bilateral
lymphadenopathy with Transbronchial Improvement with
diﬀuse ground glass
biopsy
methylprednisolone
opacities

Acid-fast bacillary and fungal cultures remained negative. No crystals were seen on polarized microscopy.

3. Discussion
Overall, African Americans have a threefold age-adjusted
annual incidence of sarcoidosis when compared to Caucasians [1].
There is no diagnostic laboratory or imaging study
available. A joint consensus statement recommends three
criteria for the diagnosis of sarcoidosis: (a) a compatible
clinical and radiologic presentation, (b) pathologic evidence of
noncaseating granulomas, and (c) exclusion of other diseases
with similar ﬁndings [2]. Clinical suspicion is critical for diagnosing sarcoidosis, a constellation of consistent symptoms,
and supporting imaging is of paramount importance.
Although the initial diagnosis is made on clinicoradiographic ﬁndings, a tissue biopsy is warranted to conﬁrm
the diagnosis. The presence of noncaseating granulomas
demonstrated on microscopic evaluation is typical. However, other granulomatous disorders need to be excluded
before a determination can be made. The diagnosis is made
even more diﬃcult when clinical suspicion is low, owing to
diﬀerent presentations like in our case.
Our patient met the Berlin criteria for ARDS at presentation. Owing to the lack of a satisfactory underlying
diagnosis, an extensive workup [3] was performed which
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remained negative. She succumbed to her illness, primarily
from worsening ARDS and right heart failure. The demonstration of granulomata in the mediastinal nodes, pulmonary parenchyma, and hepatic tissue suggested the
diagnosis posthumously, which was made after staining and
culture for microbial pathogens, including mycobacteria and
fungi.
Sarcoidosis does not generally cause a fulminant pulmonary syndrome, as in our patient. Only scattered case
reports exist of febrile illness attributed to sarcoidosis
outside of the well-described Heerfordt-Waldenström
syndrome, also referred to as sarcoid uveoparotid fever [4].
An acute manifestation of sarcoidosis most commonly
presents as Löfgren’s syndrome, characterized by the classic
triad of hilar adenopathy, erythema nodosum, and arthritis.
Lung involvement is most common in sarcoidosis.
However, acute respiratory failure and acute respiratory
distress syndrome are incredibly rare initial presentations of
sarcoidosis, with a handful of reports in the literature [5–12].
Table 1 provides some details about reported cases.
Interestingly, acute febrile presentations appear to be
extremely rare. Suyuma et al. have previously described a
similar patient with high fevers and acute respiratory failure
diagnosed subsequently as pulmonary sarcoidosis [12].
Previously, authors have termed a rapidly manifesting
variant as alveolar sarcoidosis, owing to the acuity of onset
and radiologic pattern consistent with diﬀuse alveolar
inﬁltrates and presence of air bronchograms. Interestingly, most patients diagnosed with alveolar sarcoidosis also did not present with respiratory failure. Two
such cases have been documented, by Sahn et al. [11] and
Gera et al. [6].
An acute inﬂammatory syndrome is poorly understood
and postulated in response to the systemic activation of
T-cell-mediated immune response and activation of the
interferon-gamma and interleukin-2 pathways which can
then lead to the development of ARDS [8].
Sarcoidosis is not a usual cause of ARDS and is seldom
cited as the underlying pathology in these patients; as our
case and other cases before illustrated, it is essential to
consider this in the diﬀerential for unexplained ARDS.
This is the only reported case of ARDS from an acute
febrile presentation of sarcoidosis which was diagnosed
posthumously, highlighting the importance of considering it
in patients with ARDS from an unknown underlying disease
process.

4. Conclusion
Acute respiratory failure due to ARDS is an underrecognized
presentation of sarcoidosis and can be potentially fatal if not
treated promptly. Physicians need to be vigilant in considering sarcoidosis as a cause of ARDS after excluding
common etiologies.
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